Cargando…
Infliximab in the Treatment of Crohn Disease and Type 1 Diabetes
Autores principales: | Timper, Katharina, Hruz, Petr, Beglinger, Christoph, Donath, Marc Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687309/ https://www.ncbi.nlm.nih.gov/pubmed/23801815 http://dx.doi.org/10.2337/dc13-0199 |
Ejemplares similares
-
Pilot Studies of Wearable Outpatient Artificial Pancreas in Type 1 Diabetes
por: Cobelli, Claudio, et al.
Publicado: (2012) -
Real-world cost-effectiveness associated with infliximab maintenance therapy for moderate to severe Crohn’s disease in China
por: Shi, Ji-Hao, et al.
Publicado: (2020) -
Dietary Quality in Adolescents With Type 1 Diabetes
por: Bansal, Nidhi, et al.
Publicado: (2013) -
No Relation Between Cystic Fibrosis–Related Diabetes and Type 1 Diabetes Autoimmunity
por: Gottlieb, Peter A., et al.
Publicado: (2012) -
Global Reality of Type 1 Diabetes Care in 2013
por: Beran, David, et al.
Publicado: (2013)